We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+17.13%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$31.9B
AUM Growth
+$4.19B
Cap. Flow
+$23.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
18.87%
Holding
1,397
New
111
Increased
494
Reduced
445
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$83.9M
2
QDEL icon
QuidelOrtho
QDEL
+$75.7M
3
GXC icon
State Street SPDR S&P China ETF
GXC
+$73.7M
4
TSLA icon
Tesla
TSLA
+$58.1M
5
MSFT icon
Microsoft
MSFT
+$48.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$149M
2
HON icon
Honeywell
HON
+$72.2M
3
IBM icon
IBM
IBM
+$66M
4
INTC icon
Intel
INTC
+$63.3M
5
LMND icon
Lemonade
LMND
+$56M

Sector Composition

Rank Sector Weight
1 Technology 30.89%
2 Healthcare 17.61%
3 Consumer Discretionary 11.58%
4 Financials 10.48%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXM icon
1076
Oxford Industries
OXM
$581M
$387K ﹤0.01%
5,900
-2,900
-33% -$150K
EXPE icon
1077
Expedia Group
EXPE
$36.5B
$382K ﹤0.01%
2,892
+163
+6% +$18.4K
JNCE
1078
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$374K ﹤0.01%
53,400
VAR
1079
DELISTED
Varian Medical Systems, Inc.
VAR
$374K ﹤0.01%
2,138
+281
+15% +$48.7K
FITB
1080
Fifth Third Bancorp
FITB
$51.3B
$370K ﹤0.01%
+13,421
New +$339K
SPNT icon
1081
SiriusPoint
SPNT
$3.03B
$366K ﹤0.01%
38,400
ST icon
1082
Sensata Technologies
ST
$6.69B
$364K ﹤0.01%
+6,900
New +$332K
IMGN
1083
DELISTED
Immunogen Inc
IMGN
$364K ﹤0.01%
56,400
HURC icon
1084
Hurco Companies Inc
HURC
$132M
$359K ﹤0.01%
11,963
WDC icon
1085
Western Digital
WDC
$159B
$358K ﹤0.01%
8,547
-1,344
-14% -$44.6K
TUP
1086
DELISTED
Tupperware Brands Corporation
TUP
$356K ﹤0.01%
+11,000
New +$324K
MTB icon
1087
M&T Bank
MTB
$36.3B
$351K ﹤0.01%
2,756
-26,258
-91% -$2.99M
CORT icon
1088
Corcept Therapeutics
CORT
$9.98B
$348K ﹤0.01%
13,300
MAR icon
1089
Marriott International
MAR
$100B
$347K ﹤0.01%
2,623
+6
+0.2% +$685
BBBY
1090
DELISTED
Bed Bath & Beyond Inc
BBBY
$346K ﹤0.01%
+19,500
New +$405K
COWN
1091
DELISTED
Cowen Inc. Class A Common Stock
COWN
$346K ﹤0.01%
+13,300
New +$300K
MGM icon
1092
MGM Resorts International
MGM
$11.7B
$343K ﹤0.01%
+10,885
New +$280K
POR icon
1093
Portland General Electric
POR
$5.82B
$342K ﹤0.01%
8,001
+1,700
+27% +$69.3K
ENTA icon
1094
Enanta Pharmaceuticals
ENTA
$362M
$341K ﹤0.01%
8,100
+300
+4% +$13.2K
SON icon
1095
Sonoco
SON
$5.83B
$338K ﹤0.01%
5,700
-28,800
-83% -$1.62M
UBA
1096
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$335K ﹤0.01%
23,700
GDOT icon
1097
Green Dot
GDOT
$750M
$329K ﹤0.01%
5,900
-4,100
-41% -$233K
UMC icon
1098
United Microelectronic
UMC
$42.9B
$323K ﹤0.01%
38,300
-95,763
-71% -$625K
HAPN
1099
Happen Inc
HAPN
$2.14B
$322K ﹤0.01%
+30,500
New +$204K
UCTT
1100
Ultra Clean Holdings
UCTT
$3.12B
$321K ﹤0.01%
10,300
-6,900
-40% -$193K

Similar funds

Axa's Q4 2020 Portfolio in Review

As of Q4 2020, Axa held 1,397 positions worth $31.9B, up 15% from $27.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2020 filing shows 111 new, 494 increased, 445 reduced and 146 closed positions. Its largest new stake was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M. The largest sale was Linde, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2020 buy was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M.
  • Axa added most to Amazon in Q4 2020, an estimated $83.9M increase.
  • Axa's biggest Q4 2020 reduction was Linde, cutting an estimated $149M.
  • Axa fully exited Jumia Technologies in Q4 2020, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 19% of its $31.9B portfolio in Q4 2020.
  • Axa opened 111 new positions and closed 146 in Q4 2020.
  • Axa's portfolio value rose 15% quarter-over-quarter to $31.9B.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.